Has Noffar Bar, MD received payments from drug or device companies?

Yes. Drug and device makers reported $6,588 in general payments to Noffar Bar, MD across 23 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Noffar Bar, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Noffar Bar, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Noffar Bar, MD

Medical Oncology · New Haven, CTNPI 1215179106

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $4,905 of the $6,588 with a category attached, or 74.5%. 6 manufacturers reported payments, led by Janssen Scientific Affairs, LLC at 43.4% of the total.

$6,588in general payments, 2019–2025

Across 23 payments — averaging $286.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Janssen Scientific Affairs, LLC$3K
Johnson & Johnson$2K
Sanofi$569
Janssen Research & Development, LLC$405
Seagen Inc.$242
Sanofi Pasteur Inc.$45

$5,397,301in research payments, 2019–2025

Across 186 payments — averaging $29,018 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Bristol Myers Squibb$3.7M
Janssen Research & Development, LLC$1.6M
E.r. Squibb & Sons, L.L.C.$61K
AbbVie$21K

What the payments were for

Consulting fees$4,90574%
Travel & lodging$2454%
Food & beverage$1,43822%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Janssen Scientific Affairs, LLC	2	$2,858
Johnson & Johnson	7	$2,469
Sanofi	5	$569
Janssen Research & Development, LLC	5	$405
Seagen Inc.	2	$242
Sanofi Pasteur Inc.	2	$45

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

DARZALEX$3,950
CARVYKTI$3,358
TECVAYLI$2,048
TALVEY$2,048
SARCLISA$414

How this compares

$6,588 in reported general payments places this provider in the 60th percentile of 79 medical oncology providers in Connecticut.

See all medical oncology providers in Connecticut →

Medicare billing

Part B allowed, 2024

$46,912

Medicare patients

142

Services billed

459

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
BrukinsaZanubrutinib	12	$151,625
EliquisApixaban	31	$25,933
Acyclovir	73	$1,149
Ondansetron OdtOndansetron	19	$532
Dexamethasone	22	$449
Gabapentin	13	$69
Amlodipine Besylate	17	$28

Paid to pharmacies, not to this prescriber.

Other medical oncology in New Haven

Peter MarksNew Haven$578K
Daniel PetrylakNew Haven$446K
Mandar MuzumdarNew Haven$371K
Barbara BurtnessNew Haven$297K
Ian KropNew Haven$219K
Francine FossNew Haven$193K
Anne ChiangNew Haven$158K
Mario SznolNew Haven$157K
Lajos PusztaiNew Haven$152K
Howard HochsterNew Haven$133K

See the full list for Connecticut →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →